EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›FLYE

FLYE

Fly-E Group, Inc.

Next earnings Jun 30, 2026

Avoid
$2.14
▲ +5.42%
$2.14▼ -97.67%
over 1Y
L $1.67EODHDH $155.20
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.4%
1W+5.4%
1M+16.9%
3M+2.7%
YTD-74.3%
1Y-97.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)

Revenue fell -21.0% YoY.

Revenue (FY2025) $25.4M · FY2025

Fly-E Group, Inc. shows $25.4M in FY2025 revenue (-21.0% YoY), a -20.8% net margin, and -53.8% ROE.

Financials · annual, by fiscal year

Line itemFY23FY24FY25
Revenue$21.8M$32.2M$25.4M
Gross profit$8.29M$13.1M$10.5M
Operating income$2.31M$3.26M-$4.56M
Net income$1.38M$1.90M-$5.29M
Diluted EPS———
Net margin6.3%5.9%-20.8%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$38.0M
EV / EBITDA—
EV / Sales1.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-13.7%
FCF yield-30.2%

Quality & risk

ROIC (est.)-36.3%
Free cash flow-$11.7M
Total debt$101K
Net cash$739K
Altman Z-Score1.29 distress
Piotroski F-Score3/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-26.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-04-21). Worth a closer look.
  1. 8-K Shareholder vote2026-06-17
  2. DEF 14A Proxy statement2026-05-26
  3. 8-K Other event2026-04-27
  4. 8-K Delisting notice2026-04-21
  5. 10-Q Quarterly report2026-04-21
  6. 8-K Auditor change2026-03-12
  7. 8-K Delisting notice2026-03-05
  8. NT 10-Q Late filing notice2026-02-17
  9. 8-K Officer / director change2026-02-05

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-17open ↗ARSPeriod ending 2025-03-312026-05-26open ↗DEF 14APeriod ending 2026-06-172026-05-26open ↗PRE 14APeriod ending 2026-05-122026-05-13open ↗8-KPeriod ending 2026-04-222026-04-27open ↗10-QPeriod ending 2025-12-312026-04-21open ↗8-KPeriod ending 2026-04-172026-04-21open ↗8-KPeriod ending 2026-03-062026-03-12open ↗8-KPeriod ending 2026-02-272026-03-05open ↗NT 10-QPeriod ending 2025-12-312026-02-17open ↗8-KPeriod ending 2026-02-022026-02-05open ↗8-KPeriod ending 2025-12-222025-12-29open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueA-
GrowthF
ProfitabilityF
Financial healthC
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
Revenue
$25.4M
-21.0% YoY
Net margin
-20.8%
ROE
-53.8%
P/E
—

SEC fundamentals · FY 2025

'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$25.4M-21.0%
Net income-$5.29M-379.2%
Gross profit$10.5M-20.3%
Operating income-$4.56M-239.9%
Cash & equivalents$840K-40.1%
Total assets$33.7M+16.3%
Total liabilities$23.9M+7.6%
Stockholders' equity$9.83M+45.0%
Gross: 41.1%Op.: -17.9%L/E: 2.43x

Frequently asked

Is Fly-E Group, Inc. (FLYE) a buy?
FLYE currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue fell -21.0% YoY.
What is Fly-E Group, Inc.'s quality score?
FLYE scores 42.68627450980392/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001975940, latest 10-Q filed 2026-04-21) · EODHD · as of 6/24/2026, 2:34:04 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Earnings history

beat/miss · move
2025-07-16—▲ 0.00%8-K ↗
2025-02-20—▼ -1.83%8-K ↗
2024-11-20—▼ -9.95%8-K ↗
2024-08-19—▼ -17.89%8-K ↗
2024-07-01—▲ +2.81%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE)Bearish
globenewswire.com· 2026-01-20
Fly-E group announces receipt of delinquency notice from NasdaqBullish
seekingalpha.com· 2025-12-05
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-QBullish
globenewswire.com· 2025-12-05
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)Bearish
globenewswire.com· 2025-12-01
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmBullish
globenewswire.com· 2025-11-13
Shareholders of Fly-E Group, Inc. Should Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights – FLYEBearish
globenewswire.com· 2025-11-10

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score43 vs 67
Revenue growth-21.0% vs 7.1%
Net margin-20.8% vs 10.5%
Return on equity-53.8% vs 12.3%
P/E— vs 25.5